Skip to content

Surgical treatment for liver metastases from gastric cancer: a prospective cohort study

Surgical treatment for liver metastases from gastric cancer: a prospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015639
Enrollment
Unknown
Registered
2018-04-12
Start date
2018-04-11
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomach neoplasms

Interventions

treatment group:Surgery therapy
control group:none

Sponsors

Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Histologically confirmed primary gastric cancer; 2. The number of liver metastasis tumor is less than 10, the maximum diameter of the tumor less than 5cm; 3. presence of synchronous or metachronous liver metastasis (primary resection of the gastric cancer); 4. Child-Pugh liver function rating grade B or better (=7); 5. Aged more than 18 years and less than 75 years; 6. ECOG PS score: 0-2 points; 7. The main organ function is normal.

Exclusion criteria

Exclusion criteria: 1. Patients with metastasis other than liver metastasis; 2. Patients with synchronous or metachronous double cancer; 3. Other clinical trials at present or 4 weeks before admission; 4. Fail to complete the required inspection; 5. The expected survival time is less than 3 months; 6. examiners believe that there are sufficient reasons for disqualification from registration research.

Design outcomes

Primary

MeasureTime frame
Overall survival;

Secondary

MeasureTime frame
Progression-free Survival;

Countries

China

Contacts

Public ContactJing Yuanming

Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University

amaeba@usx.edu.cn+86 13957595256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026